Henan Hualun Pharmaceutical

Henan Hualun Pharmaceutical (officially Henan Hualun Technology Co., Ltd.) is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of veterinary medicines, active pharmaceutical ingredients (APIs), and feed additives. Founded in 1999 and headquartered in Zhengzhou, the company operates a large-scale, GMP-certified production facility in Xinxiang. Its product portfolio is primarily focused on veterinary antibiotics, including tylosin, enrofloxacin, and ceftiofur, as well as human pharmaceutical intermediates such as betaxolol hydrochloride. Henan Hualun is recognized as a key global supplier in the tylosin market and maintains strong R&D collaborations with several Chinese agricultural and medical universities. The company serves both domestic and international markets, exporting products to Southeast Asia, Europe, and the Middle East.